Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Autor: Rose AM; Epiconcept, Paris, France., Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden., Sandonis Martín V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Mazagatos C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Petrović G; Croatian Institute of Public Health, Zagreb, Croatia., Baruch J; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta., Denayer S; Sciensano, Brussels, Belgium., Seyler L; Universitair Ziekenhuis Brussel, Brussels, Belgium., Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Launay O; Inserm, CIC Cochin-Pasteur, Paris, France.; AP-HP, Hôpital Cochin, Paris, France.; Faculty of Medicine, University of Paris City, Paris, France., Machado A; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Burgui C; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Vaikutyte R; Lithuanian University of Health Sciences, Kaunas, Lithuania., Niessen FA; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Loghin II; St. Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.; Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania., Husa P; Faculty of Medicine, Masaryk University, Brno, Czechia.; University Hospital Brno, Brno, Czechia., Aouali N; Luxembourg Institute of Health, Luxembourg., Panagiotakopoulos G; National Public Health Organisation (EODY), Athens, Greece., Tolksdorf K; Robert Koch Institute, Berlin, Germany., Horváth JK; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Howard J; Epiconcept, Paris, France., Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Gallardo V; Dirección General de Salud Pública y Ordenación Farmacéutica, Junta de Andalucía, Spain., Nonković D; Teaching Public Health Institute of Split-Dalmatia County, Split, Croatia., Džiugytė A; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta., Bossuyt N; Sciensano, Brussels, Belgium., Demuyser T; Universitair Ziekenhuis Brussel, Brussels, Belgium., Duffy R; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Luong Nguyen LB; AP-HP, Hôpital Cochin, Paris, France., Kislaya I; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Martínez-Baz I; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Gefenaite G; Faculty of Medicine, Lund University, Lund, Sweden.; Lithuanian University of Health Sciences, Kaunas, Lithuania., Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Popescu C; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Součková L; University Hospital Brno, Brno, Czechia., Simon M; Centre Hospitalier de Luxembourg, Luxembourg., Michelaki S; National Public Health Organisation (EODY), Athens, Greece., Reiche J; Robert Koch Institute, Berlin, Germany., Ferenczi A; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Delgado-Sanz C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Lovrić Makarić Z; Croatian Institute of Public Health, Zagreb, Croatia., Cauchi JP; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta., Barbezange C; Sciensano, Brussels, Belgium., Van Nedervelde E; Universitair Ziekenhuis Brussel, Brussels, Belgium., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Durier C; Inserm, US19, Villejuif, Paris, France., Guiomar R; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Castilla J; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Jonikaite I; Lithuanian University of Health Sciences, Kaunas, Lithuania., Bruijning-Verhagen PC; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Lazar M; 'Cantacuzino' National Military Medical Institute for Research-Development, Bucharest, Romania., Demlová R; Faculty of Medicine, Masaryk University, Brno, Czechia., Wirtz G; Centre Hospitalier de Luxembourg, Luxembourg., Amerali M; National Public Health Organisation (EODY), Athens, Greece., Dürrwald R; Robert Koch Institute, Berlin, Germany., Kunstár MP; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Kissling E; Epiconcept, Paris, France., Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden., Valenciano M; Epiconcept, Paris, France.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Nov; Vol. 28 (47).

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.

Autor: Kissling E; Epiconcept, Paris, France., Hooiveld M; Nivel, Utrecht, the Netherlands., Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., William N; Public Health Scotland, Glasgow, United Kingdom., Vilcu AM; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Kooijman MN; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Ilić M; Croatian Institute of Public Health, Zagreb, Croatia., Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Machado A; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom., Lazar M; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania., Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Brytting M; The Public Health Agency of Sweden, Stockholm, Sweden., Casado I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Larrauri A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., Murray JK; Public Health Scotland, Glasgow, United Kingdom., Behillil S; Unité de Génétique Moléculaire des Virus à ARN, UMR 3569 CNRS, Université Paris Diderot SPC, Institut Pasteur, Paris, France.; CNR des virus des infections respiratoires, Institut Pasteur, Paris, France., de Gier B; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Mlinarić I; Croatian Institute of Public Health, Zagreb, Croatia., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Tsang R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom., Timnea O; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania., de Lange M; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Riess M; The Public Health Agency of Sweden, Stockholm, Sweden., Castilla J; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Hamilton M; Public Health Scotland, Glasgow, United Kingdom., Falchi A; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France., Knol MJ; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Kurečić Filipović S; Croatian Institute of Public Health, Zagreb, Croatia., Dunford L; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Guiomar R; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Cogdale J; UK Health Security Agency, United Kingdom., Cherciu C; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania., Jansen T; Nivel, Utrecht, the Netherlands., Enkirch T; The Public Health Agency of Sweden, Stockholm, Sweden., Basile L; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública, Catalunya, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Connell J; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Gomez V; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Sandonis Martín V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden., Rose AM; Epiconcept, Paris, France., Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden., Valenciano M; Epiconcept, Paris, France.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2022 May; Vol. 27 (21).